23andMe Capital Raised

Embed Graph

23andMe Valuation

Embed Graph

23andMe Funding Rounds Summary

23andMe's latest funding round in July 2018 was reported to be $300 m. In total, 23andMe has raised $829.5 m. 23andMe's latest valuation is reported to be $1.7 b.

23andMe Funding Rounds

DateAmount RaisedPost-money ValuationInvestors

Series A

May 2007$9.0 m$48.5 mGenentech, Google, Mohr Davidow Ventures, New Enterprise Associates, Stephens Investment Management

Series B

Dec 2009$27.8 m$150.5 mGoogle, New Enterprise Associates, Sergey Brin

Series C

Nov 2010$31.2 m$184.5 mGV, Johnson & Johnson Development Corporation, MPM Capital, New Enterprise Associates

Series D

Dec 2012$58.4 m$288.7 mAnne Wojcicki, DST Global, GV, MPM Capital, New Enterprise Associates, Sergey Brin

Grant

Jul 2014$1.4 m

Series E

Jun 2015$150.0 m$1.1 bCasdin Capital, EquityZen, GV, Illumina, MPM Capital, New Enterprise Associates, WuXi Healthcare Ventures, Xfund

Grant

Oct 2016$1.7 m$1.1 bNational Institutes of Health

Series F

Sep 2017$250.0 m$1.7 bAltimeter Capital, Casdin Capital, Euclidean Capital, Fidelity Investments, Sequoia Capital, Wallenberg Foundations

Private Equity

Jul 2018$300.0 mGlaxoSmithKline
Report incorrect company information